Could a pill of gut bacteria help treat a rare liver disease?
NCT ID NCT06197308
First seen May 21, 2026 · Last updated May 21, 2026
Summary
This early study tests whether an oral treatment made from gut bacteria is safe and doable for people with primary sclerosing cholangitis (PSC), a rare liver disease. About 28 adults aged 18-76 will take the therapy and be monitored for side effects and completion of the full course. The goal is to gather initial safety data to plan larger future trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55414, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.